Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant Tuberculosis Patients: Implementation in Dr. Soetomo General Academic Hospital, Indonesia.
Soedarsono SoedarsonoNi Made MertaniasihTutik KusmiatiAriani PermatasariSusi SubaySuko Hari AdionoPublished in: International journal of mycobacteriology (2024)
Individual regimens containing bedaquiline with delamanid was proven to provide similar efficacy and safety profiles with individual regimens containing bedaquiline without delamanid. Delamanid should be preferred when selecting drugs to complete the treatment regimen when drugs in groups A and B can not be used.
Keyphrases
- multidrug resistant
- drug resistant
- gram negative
- acinetobacter baumannii
- klebsiella pneumoniae
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- primary care
- mycobacterium tuberculosis
- chronic kidney disease
- peritoneal dialysis
- cystic fibrosis
- emergency department
- adverse drug
- patient reported outcomes
- drug induced
- escherichia coli
- hiv aids
- combination therapy